HOPE DUKES: Open Payments
NPI 1134720261 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 55 payments from 12 companies in 2025. Trend: 2023 $1,172 · 2024 $1,024 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $228 |
| Novo Nordisk Inc | 12 | $206 |
| AstraZeneca Pharmaceuticals LP | 7 | $164 |
| PFIZER INC. | 8 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| Lilly USA, LLC | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Amgen Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: Wegovy, NURTEC ODT, QULIPTA, TRINTELLIX, AIRSUPRA, UBRELVY, FARXIGA, Kerendia.
Industry payments across FL — which companies pay providers there.
